Dadoo Rajeev
SEC insider (Form 3/4/5 filer). CIK 0001951685. Director at ARS Pharmaceuticals, Inc. (SPRY). 2 reported Form 4/5 transactions since Sep 2024; latest on Jun 24, 2026. Located in REDWOOD CITY, CA.
Companies Dadoo Rajeev has filed insider reports for
- ARS Pharmaceuticals, Inc. (SPRY): Director
Dadoo Rajeev
CIK: 0001951685
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
SPRY
ARS Pharmaceuticals, Inc.
Director